Literature DB >> 21130800

Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.

Michael J Seminerio1, Nidhi Kaushal, Jamaluddin Shaikh, Jason D Huber, Andrew Coop, Rae R Matsumoto.   

Abstract

Methamphetamine interacts with sigma (σ) receptors and AC927, a selective σ receptor ligand, protects against methamphetamine-induced dopaminergic neurotoxicity. In the present study, the effects of AC927 on methamphetamine-induced hyperthermia and striatal serotonergic neurotoxicity were evaluated. Male, Swiss Webster mice were injected (i.p.) every 2 h, for a total of four times, with one of the following treatments: Saline+Saline; Saline+Methamphetamine (5 mg/kg); AC927 (5, 10, 20 mg/kg)+Methamphetamine (5 mg/kg); or AC927 (5, 10, 20 mg/kg)+Saline. Pretreatment with AC927 (10 mg/kg) significantly attenuated methamphetamine-induced striatal serotonin depletions, striatal serotonin transporter reductions, and hyperthermia. At the doses tested, AC927 itself had no significant effects on serotonin levels, serotonin transporter expression, or body temperature. To evaluate the effects of higher ambient temperature on methamphetamine-induced neurotoxicity, groups of mice were treated at 37 °C. Overall, there was an inverse correlation between the body temperature of the animals and striatal serotonin levels. Together, the data suggest that AC927 (10 mg/kg) protects against methamphetamine-induced neurotoxicity. The reduction of methamphetamine-induced hyperthermia by AC927 may contribute to the observed neuroprotection in vivo.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130800      PMCID: PMC3726056          DOI: 10.1016/j.pbb.2010.11.023

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  58 in total

Review 1.  Role of the preoptic-anterior hypothalamus in thermoregulation and fever.

Authors:  J A Boulant
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

2.  Molecular cloning and pharmacological characterization of the rat sigma1 receptor.

Authors:  J Mei; G W Pasternak
Journal:  Biochem Pharmacol       Date:  2001-08-01       Impact factor: 5.858

3.  Time-course of methamphetamine-induced neurotoxicity in rat caudate-putamen after single-dose treatment.

Authors:  G D Cappon; C Pu; C V Vorhees
Journal:  Brain Res       Date:  2000-04-28       Impact factor: 3.252

4.  Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells.

Authors:  B J Vilner; W D Bowen
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

Review 5.  Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

Authors:  A E Fleckenstein; J W Gibb; G R Hanson
Journal:  Eur J Pharmacol       Date:  2000-10-06       Impact factor: 4.432

Review 6.  Mitochondria and calcium: from cell signalling to cell death.

Authors:  M R Duchen
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

7.  Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration.

Authors:  T Hayashi; T Maurice; T P Su
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

8.  Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes.

Authors:  Daniel Gebreselassie; Wayne D Bowen
Journal:  Eur J Pharmacol       Date:  2004-06-16       Impact factor: 4.432

9.  Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.

Authors:  Rae R Matsumoto; Jamaluddin Shaikh; Lisa L Wilson; Shreedeepalakshmi Vedam; Andrew Coop
Journal:  Eur Neuropsychopharmacol       Date:  2008-08-27       Impact factor: 4.600

10.  Regulating ankyrin dynamics: Roles of sigma-1 receptors.

Authors:  T Hayashi; T P Su
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

View more
  15 in total

1.  Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.

Authors:  Nidhi Kaushal; Matthew J Robson; Abagail Rosen; Christopher R McCurdy; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2013-12-28       Impact factor: 4.432

2.  SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.

Authors:  Matthew J Robson; Ryan C Turner; Zachary J Naser; Christopher R McCurdy; James P O'Callaghan; Jason D Huber; Rae R Matsumoto
Journal:  Exp Neurol       Date:  2014-02-06       Impact factor: 5.330

3.  Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine.

Authors:  Yuko Yasui; Tsung-Ping Su
Journal:  J Drug Alcohol Res       Date:  2016-02-20

Review 4.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

5.  Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.

Authors:  Michael J Seminerio; Matthew J Robson; Ahmed H Abdelazeem; Christophe Mesangeau; Seshulatha Jamalapuram; Bonnie A Avery; Christopher R McCurdy; Rae R Matsumoto
Journal:  AAPS J       Date:  2011-12-20       Impact factor: 4.009

6.  CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.

Authors:  Nidhi Kaushal; Michael J Seminerio; Jamaluddin Shaikh; Mark A Medina; Christophe Mesangeau; Lisa L Wilson; Christopher R McCurdy; Rae R Matsumoto
Journal:  Neuropharmacology       Date:  2011-07-07       Impact factor: 5.250

7.  AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells.

Authors:  Nidhi Kaushal; Meenal Elliott; Matthew J Robson; Anand Krishnan V Iyer; Yon Rojanasakul; Andrew Coop; Rae R Matsumoto
Journal:  Mol Pharmacol       Date:  2011-11-18       Impact factor: 4.436

8.  Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus.

Authors:  Michael J Seminerio; Matthew J Robson; Christopher R McCurdy; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2012-07-20       Impact factor: 4.432

9.  Agmatine attenuates the discriminative stimulus and hyperthermic effects of methamphetamine in male rats.

Authors:  David A Thorn; Jiuzhou Li; Yanyan Qiu; Jun-Xu Li
Journal:  Behav Pharmacol       Date:  2016-09       Impact factor: 2.293

10.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.